Spinal Anesthetics Causing Adverse Effects in Therapeutic Use

The first group (Dexamethasone) will receive 8 mg IV dexamethasone within 1-2 minutes after the umbilical cord is clamped.
The second group (Cyclizine) will receive 50 mg cyclizine within 1-2 minutes after the umbilical cord is clamped

IV Cyclizine versus IV Dexamethasone for prevention of nausea and vomiting after intrathecal morphine in patients undergoing cesarean section

Cyclizine Vs. Dexamethasone for Nausea and Vomiting Following Intrathecal Morphine in Cases of Cesarean Section

Comparison Between Cyclizine and Dexamethasone for Prevention of Nausea and Vomiting After Intrathecal Morphine in Patients Undergoing Cesarean Section

Nausea and vomiting were recorded as present or absent,
All measurements and ratings were completed at the time when patients rated their PONV intensity.
We also recorded factors known to be associated with the risk of developing PONV, including known risk factors for PONV.

0 meaning no pain at all, and 10 described as the worst pain experienced.

Mina Elia Azmy Habib

Principal Investigator

Assiut University

The patients will receive oral placebo tablet, one hour before induction of anesthesia and 5 mg Intra-venous dexamethasone within 1-2 minutes after the umbilical cord is clamped.

The patients will receive 250 mg oral Azithromycin tablet, one hour before induction of anesthesia and 5 mg Intra-venous dexamethasone within 1-2 minutes after the umbilical cord is clamped.

Post-operative Nausea and Vomiting

Oral azithromycin tablet will be given one hour before induction of anaesthesia.

Oral Azithromycin tablet

5 mg of intravenous dexamethasone is given within one to two minutes after the umbilical cord is clamped.

Intravenous dexamethasone

Effect of Using Azithromycin Versus Placebo With Dexamethasone in Prevention of Post-spinal Nausea and Vomiting.

Effect of Adding Azithromycin to Dexamethasone in Preventing Post-operative Nausea and Vomiting in Caesarean Section Under Spinal Anesthesia With Spinal Opiate.

Did you experience nausea during the first 24 hours after your surgery?
yes
no [if no, please skip to question 5]
How long did the nausea last? ....... hours.
How would you describe the nausea at its worst?
mild
moderate
severe
intolerable
How many times you felt nauseated? ......
Did you experience vomiting during the first 24 hours after your surgery?
yes
no [ if no, please skip the next part of the questionnaire]
How would you describe the vomiting at its worst?
mild
moderate
severe
intolerable
How many times you vomited during the first 24 hours after your surgery? .......
Estimate the amount of the vomiting?
small amount
moderate amount
large amount

KAGergis

principal investigator

whole blood, serum, white cells, red blood cells, urine, breast milk, meconium

Exposure to Environmental Pollution

Rambam Medical Center

Lis Medical Center

Assaf Harofeh Medical Center

Impact of Exposure to Environmental Pollutants on Birth Outcomes in an Israeli Cohort

assessment of BFRs and phthalates body burdens through measurement of these chemicals in maternal and paternal serum and urine, cord blood, breastmilk and neonatal meconium among several representative sub-populations

To examine associations between exposure to PBDEs and phthalates and (a) pregnancy complications, (b) anthropometrics at birth (i.e. birth weight adjusted for gestational age, ponderal index, head circumference adjusted for gestational age), and (c) cryptorchidism incidence, (d) maternal and infant thyroid function

To establish a bio repository of these media for future studies and to establish follow up methods for this cohort to later assess development and growth in the infants, toddlers and children

hydrocarbon/povraćanje

Cyclizine Vs. Dexamethasone for Nausea and Vomiting Following Intrathecal Morphine in Cases of Cesarean Section

Effect of Using Azithromycin Versus Placebo With Dexamethasone in Prevention of Post-spinal Nausea and Vomiting.

Impact of Exposure to Environmental Pollutants on Birth Outcomes in an Israeli Cohort

Najkompletnija baza ljekovitog bilja potpomognuta naukom